Speaker illustration

Doctor Richard Whitlock

Population Health Research Institute, Hamilton (Canada)

Dr. Whitlock is a Professor of Surgery at McMaster University and a practicing cardiac surgeon at Hamilton Health Sciences. He completed his residency in cardiac surgery in 2007, a fellowship in critical care in 2008, and a research fellowship in 2012. He holds an MSc (2004) and PhD in Health Research Methodology – Clinical Epidemiology (2012) from McMaster University. His first full-time research appointment started at the Population Health Research Institute in 2012. With an H-index of 35, Dr. Whitlock has more than 120 publications in medical journals including the Lancet, Circulation, Anesthesiology, the Journal of the American College of Cardiology, the European Heart Journal, the New England Journal of Medicine, and Thrombosis and Hemostasis. Dr. Whitlock has obtained over 20 peer-reviewed grants as Principal or Co-Principal Applicant.

Vitamin K antagonists versus direct oral anticoagulants after cardiac surgery: a 31-country cohort study

Event: ESC Congress 2020

Topic: Oral Anticoagulation

Session: Oral Anticoagulation for Stroke Prevention in Atrial Fibrillation in ‘Special’ Situations

Thumbnail

Immediate dabigatran reversal: changing anticoagulation practice?

Event: ESC Congress 2017

Topic: Atrial fibrillation (AF)

Session: Immediate dabigatran reversal: changing anticoagulation practice?

Thumbnail

Cardiac emergencies: how can a reversal agent for a NOAC impact practice?

Event: ESC Congress 2016

Topic: Cardiac surgery

Session: Cardiac emergencies: how can a reversal agent for a NOAC impact practice?

Thumbnail

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb